WEDNESDAY, Dec. 4, 2024 (HealthDay News) — The sugar known as fructose could be a kind of rocket fuel for cancer cells, and lowering fructose intake could be one way to fight the disease, new research suggests. Fructose is already ubiquitous in American diets, due to the heavy use ofContinue Reading
WEDNESDAY, Dec. 4, 2024 (HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds. A special six-gene pattern can help predict who are more likely to respond well to Venclexta (venetoclax), a pill that promotes naturalContinue Reading
TUESDAY, Dec. 3, 2024 (HealthDay News) — A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show. Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell acute lymphoblastic leukemia (ALL), and more than half (55%) went into remission, accordingContinue Reading
MONDAY, Dec.2, 2024 (HealthDay News) — Doctors have potent new weapons against the deadliest cancer in America and they want to make sure they’re on the radar of current and former smokers. “Lung cancer screening is the most powerful tool we have to lower cancer [deaths],” said Dr. Timothy Mullett,Continue Reading
FRIDAY, Nov. 29, 2024 (HealthDay News) — Less than half of Americans realize that they’re increasing their risk of cancer with every beer, cocktail or shot of whiskey. Despite public health warnings about the links between drinking and cancer risk, this widespread lack of awareness is the key takeaway fromContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows. Metformin appears to help boost the benefits of immunotherapy drugs used to fight lung tumors,Continue Reading
TUESDAY, Nov. 26, 2024 (HealthDay News) — Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can’t tolerate its side effects and quit the drug. A new trial offers surprising results on the best second-line drug to use in these cases. The monoclonalContinue Reading
TUESDAY, Nov. 26, 2024 (HealthDay News) — People are three times more likely to undergo at-home colon cancer screening if they’re provided a free test, a new study says. About 30% of patients mailed a free stool test kit completed their screening within six months, compared with about 10% ofContinue Reading
MONDAY, Nov. 25, 2024 (HealthDay News) — The U.S. Supreme Court on Monday declined to hear a major tobacco company’s challenge to a federal law that would mandate graphic images on cigarette packs. Some of the proposed images include a woman with a large lump on her neck alongside theContinue Reading
MONDAY, Nov. 25, 2024 (HealthDay News) — A cancer diagnosis can bring overwhelming stress and depression to women, but new research suggests yoga can help ease that emotional toll. “A wellness intervention that integrates yoga and psychological tools may strengthen the connections among the mind, body and spirit, leading toContinue Reading